BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryerson CJ, Camp PG, Eves ND, Schaeffer M, Syed N, Dhillon S, Jensen D, Maltais F, O'Donnell DE, Raghavan N, Roman M, Stickland MK, Assayag D, Bourbeau J, Dion G, Fell CD, Hambly N, Johannson KA, Kalluri M, Khalil N, Kolb M, Manganas H, Morán-Mendoza O, Provencher S, Ramesh W, Rolf JD, Wilcox PG, Guenette JA. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study. Ann Am Thorac Soc 2016;13:1640-7. [PMID: 27348402 DOI: 10.1513/AnnalsATS.201604-267OC] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Badenes-Bonet D, Cejudo P, Rodó-Pin A, Martín-Ontiyuelo C, Chalela R, Rodríguez-Portal JA, Vázquez-Sánchez R, Gea J, Duran X, Caguana OA, Rodriguez-Chiaradia DA, Balcells E. Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial. BMC Pulm Med 2021;21:355. [PMID: 34749699 DOI: 10.1186/s12890-021-01727-9] [Reference Citation Analysis]
2 Milne KM, Domnik NJ, Phillips DB, James MD, Vincent SG, Neder JA, O'Donnell DE. Evaluation of Dynamic Respiratory Mechanical Abnormalities During Conventional CPET. Front Med (Lausanne) 2020;7:548. [PMID: 33072774 DOI: 10.3389/fmed.2020.00548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nishiyama O, Kataoka K, Ando M, Arizono S, Morino A, Nishimura K, Ogawa T, Shiraki A, Watanabe F, Kozu R, Ogura T, Kondoh Y. Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis. ERJ Open Res 2021;7:00321-2021. [PMID: 34435033 DOI: 10.1183/23120541.00321-2021] [Reference Citation Analysis]
4 Singh S, Sharma BB, Bairwa M, Gothi D, Desai U, Joshi JM, Talwar D, Singh A, Dhar R, Sharma A, Ahluwalia B, Mangal DK, Jain NK, Pilania K, Hadda V, Koul PA, Luhadia SK, Swarnkar R, Gaur SN, Ghoshal AG, Nene A, Jindal A, Jankharia B, Ravindran C, Choudhary D, Behera D, Christopher DJ, Khilnani GC, Samaria JK, Singh H, Gupta KB, Pilania M, Gupta ML, Misra N, Singh N, Gupta PR, Chhajed PN, Kumar R, Chawla R, Jenaw RK, Chawla R, Guleria R, Agarwal R, Narsimhan R, Katiyar S, Mehta S, Dhooria S, Chowdhury SR, Jindal SK, Katiyar SK, Chaudhri S, Gupta N, Singh S, Kant S, Udwadia Z, Singh V, Raghu G. Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India 2020;37:359-78. [PMID: 32643655 DOI: 10.4103/lungindia.lungindia_275_20] [Reference Citation Analysis]